MERCURI-2: The Visual Abstract

Can perioperative dapagliflozin prevent AKI after cardiac surgery?

The MERCURI-2 trial offers an intriguing answer and raises an important question about what is driving the AKI benefit.

Check out the VA for next #NephJC by Andreea Manolea

View fullsize